EC logo

Ecopetrol S.A. American Depositary Shares (EC)

$16.63

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on EC

Market cap

$34.19B

EPS

0.09

P/E ratio

216.3

Price to sales

2.78

Dividend yield

3.976%

Beta

0.4785

Price on EC

Previous close

$16.96

Today's open

$17.07

Day's range

$16.63 - $17.07

52 week range

$8.57 - $18.38

Profile about EC

CEO

Alfonso Camilo Barco Munoz

Employees

19659

Headquarters

BOGOTA D.C.,

Exchange

New York Stock Exchange

Shares outstanding

2.06B

Issue type

American Depository Receipt

EC industries and sectors

Energy

Fossil Fuels

News on EC

Ecopetrol (EC) Stock Declines While Market Improves: Some Information for Investors

In the most recent trading session, Ecopetrol (EC) closed at $16.96, indicating a -1.68% shift from the previous trading day.

news source

Zacks Investment Research • Oct 6, 2026

news preview

Ecopetrol S.A. (EC) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Ecopetrol (EC). This makes it worthwhile to examine what the stock has in store.

news source

Zacks Investment Research • Oct 5, 2026

news preview

New Strong Buy Stocks for October 5th

EC, CBRL, GCT, DG and NWL have been added to the Zacks Rank #1 (Strong Buy) List on October 5th, 2026.

news source

Zacks Investment Research • Oct 5, 2026

news preview

Best Income Stocks to Buy for October 5th

NWL, EC, DG made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 5th, 2026.

news source

Zacks Investment Research • Oct 5, 2026

news preview

Best Value Stocks to Buy for October 5th

NWL, EC and GCT made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 5th, 2026.

news source

Zacks Investment Research • Oct 5, 2026

news preview

Ecopetrol Group, in coordination with the National Government, receives payment of the Fuel Price Stabilization Fund (FEPC, by its Spanish acronym) receivable corresponding to the third and fourth quarters of 2025

BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company") hereby announces that, pursuant to coordinated efforts undertaken with the National Government of Colombia, acting through the Ministry of Finance and Public Credit (Ministerio de Hacienda y Crédito Público) and the Ministry of Mines and Energy (Ministerio de Minas y Energía), it has received payment of the outstanding receivable owed by the Fuel Price Stabilization Fund (Fondo de Estabilización de Precios de los Combustibles, "FEPC") corresponding to the third and fourth quarters of 2025.

news source

PRNewsWire • Oct 1, 2026

news preview

Ecopetrol Advances Its Transformation with Changes to Its Senior Management Team

BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company" or "Ecopetrol") announced today that its Board of Directors, at a meeting held on September 30, 2026, approved the appointment of three new members of senior management, as part of the Company's ongoing strategy to strengthen key capabilities for its next phase of development.

news source

PRNewsWire • Oct 1, 2026

news preview

Ecopetrol Announces Changes to Senior Management

BOGOTÁ, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the "Company") announced today that Cristina Toro Restrepo, Corporate Vice President of Legal Affairs and General Secretary, will continue to serve in that position through September 30, 2026, following the termination of her employment relationship by decision of the Company, effective as of that date.

news source

PRNewsWire • Oct 1, 2026

news preview

Ecopetrol (EC) Suffers a Larger Drop Than the General Market: Key Insights

Ecopetrol (EC) reached $16.52 at the closing of the latest trading day, reflecting a -1.08% change compared to its last close.

news source

Zacks Investment Research • Sep 29, 2026

news preview

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's proprietary PD‑L1/4‑1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This is the third Orphan Drug Designation for opamtistomig, following designations in the U.S. Food and Drug Administration (FDA) and the European Commission (EC), marking a further expansion of its global regulatory recognition into a strategically important Asian market.

news source

GlobeNewsWire • Sep 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Ecopetrol S.A. American Depositary Shares

Open an M1 investment account to buy and sell Ecopetrol S.A. American Depositary Shares commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in EC on M1